Cargando…
Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1
Hypoxia activates hypoxia-inducible factor 1, which promotes the progression of malignancy by stimulating angiogenesis and by augmenting the ability of tumors to survive. Thus, HIF-1 is one of the most compelling targets for treating cancers. The aim of this study was to find a small molecule that i...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308714/ https://www.ncbi.nlm.nih.gov/pubmed/27613833 http://dx.doi.org/10.18632/oncotarget.11529 |